Dadi IndustryDadi Industry


Investment Environment


Location Advantage

Advantageous traffic location

Located in the geographic center of China, Chongqing has the geographical advantages of connecting the east and the west, the north and the south, as well as the golden waterway to the sea. As an important strategic stronghold for the large-scale development of the western region and an important connection point for the “the Belt and Road Initiative” Yangtze River Economic Belt, the city covers 82,400 square kilometers, and has a permanent population of 33 million, a gross regional product of RMB 2,360,577 million and a hundred billion-scale consumer market.

Learn more

Solid foundation of biopharmaceutical industry

In the 1980s, as one of the five largest pharmaceutics bases in our country, the biopharmaceutical manufacturing industry in Chongqing was developed. As an old brand biopharmaceutical base, it is featured by a solid industrial foundation and a complete range of medical devices, and has 176 pharmaceutical companies above designated size, of which 97, 12 and 1 have an annual output value of more than RMB 0.1 billion, more than RMB 1 billion and RMB 5 billion respectively.

Learn more

Full guarantee for production factors

Abundant in water, electricity and natural gas resources, Chongqing can guarantee the energy needs of enterprises. Specifically, Shui'tu New Area of Liangjiang New Area has a municipal pipeline network of 330 kilometers, 181 communication base stations, 18 substations, 1 water plant, 2 gas distribution stations and 1 sewage treatment plant, basically forming a diversifying system with sufficient guarantee for factors and sufficient energy supply. In Liangjiang New Area, a pilot area for the national power supply side reform, the minimum electricity price is only RMB 0.55 yuan.

Learn more

Advantageous medical resource

Chongqing has a sound medical and health system: There are 19,615 medical and health institutions in the city, including 766 hospitals, ranking first among the four municipalities directly under the central administration. Specifically, 17 grade A tertiary hospitals have been approved as the national clinical drug and medical device research bases, and thus can carry out clinical research in various medical fields.

Learn more

Policy Advantage

  • Excellent political environment

    Excellent political environment

    Excellent political environment

    “New Area’s Affairs are handled in it". Chongqing, a municipality directly under the Central Government, has few administrative levels and a high administrative efficiency. Established on April 5, 2012, the “Liangjiang New Area Government Affairs Center” has the municipal-level (provincial-level) approval right within the planned area of 1,200 square kilometers in Liangjiang New Area, as authorized by the Chongqing Municipal People’s Government, with an aim of creating intelligent “one-stop” centralized approval service for the registration and project construction of the enterprises in the area. With 208 window stations, the center can provide 24-hour "no-closing" government affairs service. Also, it has actively promoted the reforms of the administrative examination and approval and super-ministry system, and introduced a number of investments facilitating and trade facilitating measures to provide enterprises with a time-saving, labor-saving and worry-free government environment and build a business environment geared to international standards.
  • To vigorously support the development of the biopharmaceutical industry

    To vigorously support the development of the biopharmaceutical industry

    To vigorously support the development of the biopharmaceutical industry

    the Chongqing Municipal People’s Government has successively issued a number of industry support policies, e.g., the Guiding Idea on Accelerating the Development of Biopharmaceutical Industry and Several Policies of Chongqing for Accelerating the Development of Biopharmaceutical Industry issued by Chongqing Municipal People’s Government. Focusing on the two main lines of "encouraging innovation" and "promoting high-quality development", the city strives to strengthen and optimize its biopharmaceutical industry by "increasing high-quality varieties, improving the manufacturing capability, supplementing platform shortcomings, and optimizing the industrial layout". Also, it has accelerated its internationalization, actively participated in the division of labor in the global biopharmaceutical industry, and comprehensively enhanced the talent and R&D levels through integrative development and coordinated development. It has vigorously implemented the standardization and branding strategies, cultivated new drivers of the biopharmaceutical industry, and comprehensively improved the development level of the biopharmaceutical industry.


Talent Advantage

Advantageous educational resource

Advantageous educational resource

There are 67 higher education schools in Chongqing, with 150,000 graduates above bachelor degree generated each year, and 4,401 vocational training institutions and 341 secondary vocational schools, with 350,000 graduates generated each year. So, the talent resource is rich.
Concentration of overseas talents

Concentration of overseas talents

Currently, top talents of the industry have gathered here. The Park is joined by members of National Academy, experts of Thousand Talents Plan, Changjiang Scholars and Hongyan Plan experts. It is surrounded by well-known large-scale pharmaceutical companies, colleges and universities, gradually forming a biopharmaceutical talent circle.

Platform Advantage

A biopharmaceutical full industry chain platform integrating CRO, CDMO, public testing service, science and technology development, R&D service, clinical tests, industrial production and cold-chain circulation service has been formed

Three Centers Multiple Platforms
Chongqing Medical Devices Quality Testing Center
Chongqing Customs Technology Center
Liangjiang New Area Life-health Industry Development Service Center
Chongqing Denali Drug Consistency Bioanalysis Platform
Pharmaron, the premier global pharmaceutical R&D service platform (ranked third in theworld)
Chongqing Loyal-Delivery Medical Treatment Cold-chain Transportation Service Platform
CUTC China National Testing Inspection and Certification
Artron Bio In Vitro Diagnostic Antigen and Antibody R&D Service Platform
Boji Biomedicals Medical Transformation Platform
Chongqing Zhongnuo Hengkang CDMO R&D Center and Orthopedic Technology Industry Platform
Chongqing iSIA Bio-technology Quantum Dots Immunochromatographic Platform
Chongqing Acelbio Large-scale Culture Reactor Platform for Plant Cells
Chongqing Peg Bio Biopharm Gene Protein Polypeptide Medicine Innovation Research and Development Platform
Chongqing CAMAB Human Antibody R&D Platform
Chongqing Advanced Medical Device Engineering Research and Development Platform of Suzhou Institute of Medical Technology, Chinese Academy of Sciences